Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

There has been some research suggesting that a type of type 2 diabetes drugs called SGLT2 inhibitors could reduce the incidence of some neurodegenerative conditions including Parkinson’s disease ...

Advertisement But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer's disease or Parkinson's disease, and a 30% ...

Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's By Dennis Thompson HealthDay Reporter THURSDAY, Sept. 19, 2024 (HealthDay News) -- A specific class of diabetes drug appears to lower ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.

Sen. William Parkinson’s bill seeking aggravated murder, murder and manslaughter charges for meth and fentanyl dealers for ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced risk of ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced ...